瘢痕疙瘩切除后真皮基质辅助重建:联合治疗方案长期结局
回顾性研究纳入2015–2023年切除后真皮基质覆盖的广泛瘢痕疙瘩66例,术后每月曲安奈德注射,中位随访4.15年成功率为65%。真皮基质联合皮片移植者复发风险显著降低(P<0.01),但20%病例出现供区瘢痕疙瘩形成。
要点
- 广泛瘢痕疙瘩切除后真皮基质联合曲安奈德注射,中位随访4.15年成功率达65%。
- 真皮基质联合皮片移植可显著降低复发风险(P<0.01)。
- 需警惕供区瘢痕疙瘩形成,本组发生率为20%。
核心结论
- 真皮基质联合术后曲安奈德注射的联合方案对广泛瘢痕疙瘩有效,成功率为65%。
- 真皮基质联合皮片移植可显著降低复发风险(P<0.01),但供区瘢痕疙瘩形成风险不可忽视(20%)。
研究设计与样本
- 回顾性研究,纳入2015–2023年治疗的广泛瘢痕疙瘩66例。
- 所有病灶完整切除后以真皮基质覆盖,行二期愈合或刃厚皮片移植,术后每月曲安奈德注射。
- 主要结局为随访结束时无复发或复发显著减少,中位随访4.15年。
主要发现
- 66例瘢痕疙瘩中位随访4.15年,联合治疗方案成功率为65%。
- 真皮基质联合皮片移植者复发风险显著降低(P<0.01)。
- 20%的病例出现供区瘢痕疙瘩形成。
关键数值与推荐
- 手术切除后以真皮基质覆盖,行二期愈合或刃厚皮片移植。
- 术后每月行曲安奈德病灶内注射。
- 真皮基质联合皮片移植与复发风险降低相关(P<0.01)。
临床怎么用
- 对广泛瘢痕疙瘩可行切除后真皮基质覆盖联合术后曲安奈德注射。
- 优先考虑真皮基质联合皮片移植以降低复发风险。
- 供区需评估瘢痕疙瘩形成风险并采取预防措施。
局限性
- 回顾性研究设计。
- 需要随机前瞻性研究进一步验证并优化患者选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Extensive keloids represent a major therapeutic challenge due to their high propensity for recurrence and their functional, aesthetic, and psychological impact. Surgical excision alone is associated with a high recurrence rate ranging from 40% to 100%. The use of a dermal regeneration matrix after excision, in combination with intralesional corticosteroid injections, has emerged as a promising alternative. This combined approach may improve healing quality and reduce recurrence, particularly in large or complex lesions. The objective of this study was to evaluate the effectiveness of this multimodal treatment protocol. METHODS: We conducted a retrospective study of extensive keloids treated between 2015 and 2023. All lesions were completely excised and covered with a dermal matrix, followed by secondary intention healing or split-thickness skin grafting. Monthly triamcinolone injections were administered postoperatively. The primary outcome measure was the absence or significant reduction of recurrence at the end of the follow-up period. RESULTS: In a cohort of 66 keloids with a median follow-up of 4.15 years, this combined therapeutic approach achieved a 65% success rate. Keloids covered with both dermal matrix and skin grafting had a significantly reduced risk of recurrence ( P < 0.01). However, donor site keloid formation occurred in 20% of cases. CONCLUSION: This combined approach offers an effective solution for extensive keloids. Skin grafting appears to reduce the risk of recurrence but carries a nonnegligible risk of keloid formation at the donor site. Randomized prospective studies are needed to further validate these findings and optimize patient selection.
引用
- Thiriez G, Ferrero L, Grobien M, et al. Dermal Matrix-Assisted Reconstruction After Keloid Excision: Long-Term Outcomes of a Combined Therapeutic Protocol. Ann Plast Surg. 2026. PMID: 41604522. doi:10.1097/SAP.0000000000004676
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。